Results 51 to 60 of about 76,651 (164)

Difficult airway management in A pediatric case with infantile hemangioma

open access: yes, 2018
Introduction: Difficult airway, one of the most fearsome situations of anesthesia practice, is a more serious problem in pediatric cases. Infantile hemangioma, the most common vascular tumour in childhood, may pose difficult airway.
Şen, Ahmet   +4 more
core   +1 more source

Oral propranolol therapy in 23 infants with infantile hemangioma [PDF]

open access: yes, 2018
Background Infantile hemangioma (IH) is a common vascular tumor in pediatric patients, and is commonly treated with propranolol. We describe our experiences with dosage, response to treatment, and side effects in 23 IH patients treated with ...
Tai Suk Roh   +3 more
core   +1 more source

Early Intervention Effects and Risk Factors for Residual Skin Changes in Infantile Hemangiomas

open access: yesThe Journal of Dermatology, Volume 53, Issue 9, Page 1296-1304, September 2026.
ABSTRACT Infantile hemangioma (IH) characteristically progresses through proliferative, involuting, and involuted phases, and typically undergoes spontaneous regression after the age of five. Therefore, the traditional management strategy has been based on a “wait‐and‐see policy”.
Kayoko Okuda   +4 more
wiley   +1 more source

Clinical case of «infantile» hemangioma: routing, tactics, method of treatment [PDF]

open access: yes, 2022
The aim of study – demonstration of a clinical case of "infantile" hemangioma, patient routing and choice of therapy.Цель исследования – демонстрация клинического случая «инфантильной» гемангиомы, маршрутизации пациента и выбора метода ...
Trunova, Y. A.   +3 more
core  

To study the role of propranolol in infantile hemangioma: A prospective randomized study

open access: yesAsian Journal of Medical Sciences
Background: Infantile capillary hemangiomas (IHs) are common, benign, self-limited tumors with a well-defined natural history, occurring most often on the head and neck. IHs are the most common soft-tissue tumors in infancy and occur in 5–10% of children.
Pokhariya BMS   +2 more
doaj   +1 more source

A Large Parotid Hemangioma Managed Successfully with Propranolol

open access: yesClinical, Cosmetic and Investigational Dermatology, 2022
Fandresena Arilala Sendrasoa, Tsiory Iarintsoa Razafimaharo, Samson Leophonte Ramily, Lala Soavina Ramarozatovo, Fahafahantsoa Rapelanoro Rabenja Department of Dermatology, Faculty of Medicine, University of Antananarivo, Antananarivo, 101 ...
Sendrasoa FA   +4 more
doaj  

Exploratory Analysis of the Inhibitory Effects of Propranolol on NLRP3 and Pyrin Inflammasomes

open access: yesACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective Propranolol, a nonselective beta receptor blocking agents, impacts cAMP levels and is commonly used to treat hypertension and hemangioma in children and adults. Although there are reports indicating its anti‐inflammatory properties, the exact mechanism is not fully understood. Methods Murine and human monocytes and macrophages were exposed to
Renske J. de Jong   +13 more
wiley   +1 more source

Unveiling Infantile Hemangiomas: A Comprehensive Study of Patterns, Presentations, and Complications

open access: yesDermatology Practical & Conceptual
Background: Infantile Hemangioma is the most common vascular tumor in infants, affecting 4% to 10% of this population. It typically appears as a solitary cutaneous hemangioma but can also be multifocal or segmental.
Prashansa Jaiswal   +4 more
doaj   +1 more source

The treatment of hemangioma of the larynx in children is still a dilemma [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2019
Introduction. The laryngeal hemangioma in children is a benign vascular neoplasm but it could become malignant after localization. Case outline. After two weeks of corticosteroid treatment in a 15-month-old boy, there were no desired results.
Stojković Anđelka   +6 more
doaj   +1 more source

Congenital aleukemic leukemia cutis mimicking infantile hemangioma

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Ana Clara Maia Palhano   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy